Literature DB >> 12884025

p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.

Marijeta Kralj1, Jasminka Pavelić.   

Abstract

PURPOSE: Although there are many controversial reports about the effect of p53 and p21(WAF1/CIP1) overexpression in different human tumor cells, the p53 gene is shown to be a more effective candidate for cancer gene therapy because of its more pronounced ability to induce apoptosis. In the present study, we present the effect of p53 and p21(WAF1/CIP1) overexpression on mouse renal carcinoma cells in vitro and in vivo.
METHODS: p53 and p21(WAF1/CIP1) genes were introduced into Renca cells using adenoviral vectors (Ad5CMV-p53 and Ad5CMV-p21). The induction of apoptosis was measured using Annexin V assay and DNA fragmentation analysis. The expression of proteins was examined using immunocytochemistry and Western blot methods. The ability of adenoviral vectors to inhibit tumorigenicity of Renca cells, as well as the growth of pre-established tumors was measured.
RESULTS: In vitro growth assays revealed higher growth suppression after Ad5CMV-p21 infection. Although both vectors induced apoptosis, Ad5CMV-p53 was slightly more efficient. In vivo studies in Balb/c mice, demonstrated that tumorigenicity was completely suppressed by Ad5CMV-p21. Besides this, Ad5CMV-p21 significantly inhibited the growth of established tumors, while Ad5CMV-p53 did not.
CONCLUSIONS: These data suggest that p21(WAF1/CIP1) is a more potent growth suppressor than p53 of mouse tumor cells Renca. The divergent responses of tumor cells to p21(WAF1/CIP1) overexpression could be due to various networks that differ between species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884025     DOI: 10.1007/s00432-003-0458-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  39 in total

Review 1.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

Review 2.  Development and application of adenoviral vectors for gene therapy of cancer.

Authors:  W W Zhang
Journal:  Cancer Gene Ther       Date:  1999 Mar-Apr       Impact factor: 5.987

Review 3.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.

Authors:  S V Ekholm; S I Reed
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 4.  Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.

Authors:  Igor B Roninson
Journal:  Cancer Lett       Date:  2002-05-08       Impact factor: 8.679

5.  Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

Authors:  U S Joshi; S T Dergham; Y Q Chen; M C Dugan; J D Crissman; V K Vaitkevicius; F H Sarkar
Journal:  Pancreas       Date:  1998-03       Impact factor: 3.327

Review 6.  Gene therapy for cancer: what have we done and where are we going?

Authors:  J A Roth; R J Cristiano
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

7.  Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting.

Authors:  G D'Orazi; A Marchetti; M Crescenzi; S Coen; A Sacchi; S Soddu
Journal:  J Gene Med       Date:  2000 Jan-Feb       Impact factor: 4.565

8.  Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.

Authors:  M S Sheikh; H Rochefort; M Garcia
Journal:  Oncogene       Date:  1995-11-02       Impact factor: 9.867

9.  High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.

Authors:  W W Zhang; X Fang; W Mazur; B A French; R N Georges; J A Roth
Journal:  Cancer Gene Ther       Date:  1994-03       Impact factor: 5.987

10.  Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

Authors:  G L Clayman; T J Liu; S M Overholt; S R Mobley; M Wang; F Janot; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-05
View more
  3 in total

1.  Adenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment.

Authors:  Sandra Kraljević Pavelić; Marko Marjanović; Miroslav Poznić; Marijeta Kralj
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-23       Impact factor: 4.553

2.  Rebamipide inhibits gastric cancer cell growth.

Authors:  Tetsuya Tanigawa; Rama Pai; Tetsuo Arakawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

Review 3.  Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway.

Authors:  Ramy F Youssef; Nicholas G Cost; Oussama M Darwish; Vitaly Margulis
Journal:  Arab J Urol       Date:  2012-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.